Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease

Summary: Steatotic liver disease (SLD) is the leading cause of chronic liver disease in Europe, with liver fibrosis representing the strongest predictor of liver-related outcomes and an important contributor to cardiometabolic risk. This Series paper examines diagnostic innovation and models of care...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Nicola Pugliese, Trenton M. White, Paul N. Brennan, Silvana Pannain, Hannes Hagström, Maurice Michel, Lisa Rice-Duek, Giovanni Targher, Cyrielle Caussy, John F. Dillon, Frank Tacke, Christopher J. Kopka, Giada Sebastiani, Jerome Boursier, Emmanuel A. Tsochatzis, Willem Pieter Brouwer, Giovanni Guaraldi, Roberto Vettor, Maja Thiele, Michael Roden, Norbert Stefan, Helen Jarvis, Pere Gines, Jörn M. Schattenberg, Elisa Pose, Stefan Buttigieg, Christopher D. Byrne, Jeffrey V. Lazarus
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Elsevier 2026-06-01
Seri Bilgileri:	The Lancet Regional Health. Europe
Konular:	MASLD metALD Non-invasive tests Diagnostic innovation Fibrosis detection Risk stratification
Online Erişim:	http://www.sciencedirect.com/science/article/pii/S2666776226001341
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!